MAD1L1 Antikörper
-
- Target Alle MAD1L1 Antikörper anzeigen
- MAD1L1 (MAD1 Mitotic Arrest Deficient-Like 1 (MAD1L1))
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser MAD1L1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant fusion protein of human MAD1L1 (NP_001013859.1).
- Isotyp
- IgG
- Top Product
- Discover our top product MAD1L1 Primärantikörper
-
-
- Applikationshinweise
- WB 1:500-1:2000 IHC 1:50-1:200 IF 1:50-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- MAD1L1 (MAD1 Mitotic Arrest Deficient-Like 1 (MAD1L1))
- Andere Bezeichnung
- MAD1L1 (MAD1L1 Produkte)
- Hintergrund
- MAD1L1 is a component of the mitotic spindle-assembly checkpoint that prevents the onset of anaphase until all chromosome are properly aligned at the metaphase plate. MAD1L1 functions as a homodimer and interacts with MAD2L1. MAD1L1 may play a role in cell cycle control and tumor suppression. Alternative splicing results in multiple transcript variants.
- Molekulargewicht
-
Observed_MW: 95 kDa
Calculated_MW: 72 kDa/83 kDa
- Gen-ID
- 8379
- UniProt
- Q9Y6D9
- Pathways
- M Phase
-